Skip to main content

Tower Research Capital LLC (TRC)

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1533421 NEW YORK, NY

Position in CRVS

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$97,438
-$39,527 QoQ
Shares Held
6,522
-30.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#141
of 174 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. CRVS ranks #77 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $97,438 6,522
2026-03-31 $136,965 9,362
2025-12-31 $4,858 631
2025-09-30 $18,329 2,487
2025-06-30 $16,904 4,226
2025-03-31 $9,536 2,999
2024-12-31 $73,947 13,822
2024-06-30 $27,845 15,300
2024-03-31 $20,489 11,511
2023-12-31 $14,965 8,503
2023-09-30 $36,115 24,737
2023-06-30 $47,043 20,543
2023-03-31 $11,463 12,597
2022-12-31 $10,810 12,718
2022-09-30 $9,556 11,668
2022-06-30 $9,239 9,333
2022-03-31 $4,874 2,972
2021-12-31 $42,329 17,564
2021-09-30 $102,603 21,199
2021-06-30 $20,436 7,654
2021-03-31 $131,780 42,786
2020-12-31 $3,189 896
2020-09-30 $25,864 6,450
2020-06-30 $5,042 1,854
2020-03-31 $422 200